ELEKTA NEUROMAG AND INNOKAS MEDICAL IN AGREEMENT ON PRODUCTION OUTSOURCING

ELEKTA NEUROMAG AND INNOKAS MEDICAL IN AGREEMENT ON PRODUCTION OUTSOURCING

PRESS RELEASE	
Stockholm, Sweden, May 8, 2007

Elekta Neuromag Oy, the Finnish subsidiary of the Swedish Elekta Group, and
Innokas Medical Oy, a Finnish private company, have signed an agreement covering
production of the Elekta Neuromag® magnetoencephalography (MEG) system. The
Elekta Neuromag MEG system is used for non-invasive real-time measurements of
brain activity at leading research institutions and hospitals around the world.
The production, including the employees involved, will be transferred to Innokas
Medical during 2007.

Elekta is reinforcing its operations in the MEG business area due to the
changing market situations and the increased need for Elekta's MEG technology.
By outsourcing its MEG production to Innokas Medical, Elekta will get the
benefit of a flexible and expert medical equipment production partner, while
keeping the overall technical responsibility of the MEG system towards the
customer. Elekta will continue to invest in innovation and fulfilling the
customers' needs in the MEG area.

For Innokas Medical, this agreement is an important step in its growth strategy.
It will strengthen the company's position as a leading medical equipment
contract manufacturer in Finland.

“Non-invasive, real-time brain mapping and monitoring is considered as one of
the most exciting developments in neuroscience today and the list of new
applications for MEG is steadily growing and the number of installations are
increasing,” said Tomas Puusepp, President and CEO of Elekta. ”Elekta is the
only MEG vendor on the market with the financial stability needed to be
committed to the long-term development of MEG technology and our production
outsourcing agreement with Innokas Medical further strengthen our ability to
serve neuroscience centers around the world with leading MEG technology.”

******

For further information, please contact:

Björn Andersson, Managing Director Elekta Neuromag Oy,  
Tel. +358 9 7562 4014, e-mail: bjorn.andersson@elekta.com

Jouni Ihme, Managing Director Innokas Medical Oy, 
Tel. +358 400 689 842, e-mail: jouni.ihme@innokasmedical.fi

Peter Ejemyr, Group VP Corporate Communications, Elekta AB
Tel: +46 733 611 000 (mobile), e-mail: peter.ejemyr@elekta.com  

About Elekta

Elekta is an international medical-technology Group, providing meaningful
clinical solutions, comprehensive information systems and services for improved
cancer care and management of brain disorders. All of Elekta's solutions employ
non-invasive or minimally invasive techniques and are therefore clinically
effective, gentle on the patient and cost-effective. 

Clinical solutions include among others Leksell Gamma Knife® for non-invasive
treatment of brain disorders and Elekta Synergy® for image guided radiation
therapy (IGRT). Following the acquisition of IMPAC Medical Systems Inc. in April
2005, the Elekta Group is the world's largest supplier of oncology software. 

Elekta's systems and solutions are used at over 4,000 hospitals around the world
to treat cancer and manage clinical operations as well as to diagnose and treat
brain disorders, including tumors, vascular malformations and functional
disorders. 

With approx. 2,000 employees, Elekta's corporate headquarter is located in
Stockholm, Sweden and the company is listed on the Stockholm Stock Exchange
under the ticker EKTAb. For more information about Elekta, please visit
www.elekta.com. 

About Innokas Medical Oy 

Innokas Medical is a medical business company, founded in 1994, offering
contract design and manufacturing services to its customers. The customers are
well known international companies; many are market leaders in their own
segment. The mission of Innokas Medical is to produce health care products
behind these brands. The most important cornerstones of all company's activities
are the unconditional quality of its products and services and the commitment to
the industry and to fulfill its special requirements. Innokas Medical's quality
system is certified according to ISO standards 9001:2000 and 13485:2003. The
headquarter of the company is located in Kempele, close to Oulu, and it has
manufacturing sites in Helsinki and Estonia. The sales of the company were 5.3
M€ in 2006 and it has approx 70 employees. More information at
www.innokasmedical.fi